Your browser doesn't support javascript.
loading
Revascularization techniques for complete portomesenteric venous occlusion in patients undergoing pancreatic resection.
Harrison, Jon M; Li, Amy Y; Bergquist, John R; Ngongoni, Fari; Norton, Jeffrey A; Dua, Monica M; Poultsides, George A; Visser, Brendan C.
Afiliação
  • Harrison JM; Section of Hepatobiliary & Pancreatic Surgery, Department of Surgery, Stanford University Hospital, Stanford, CA, USA.
  • Li AY; Section of Hepatobiliary & Pancreatic Surgery, Department of Surgery, Stanford University Hospital, Stanford, CA, USA.
  • Bergquist JR; Section of Hepatobiliary & Pancreatic Surgery, Department of Surgery, Stanford University Hospital, Stanford, CA, USA.
  • Ngongoni F; Section of Hepatobiliary & Pancreatic Surgery, Department of Surgery, Stanford University Hospital, Stanford, CA, USA.
  • Norton JA; Section of Surgical Oncology, Department of Surgery, Stanford University Hospital, Stanford, CA, USA.
  • Dua MM; Section of Hepatobiliary & Pancreatic Surgery, Department of Surgery, Stanford University Hospital, Stanford, CA, USA.
  • Poultsides GA; Section of Surgical Oncology, Department of Surgery, Stanford University Hospital, Stanford, CA, USA.
  • Visser BC; Section of Hepatobiliary & Pancreatic Surgery, Department of Surgery, Stanford University Hospital, Stanford, CA, USA. Electronic address: bvisser@stanford.edu.
HPB (Oxford) ; 2024 Jul 16.
Article em En | MEDLINE | ID: mdl-39060211
ABSTRACT

INTRODUCTION:

Pancreatic pathologies causing portomesenteric occlusion complicate extirpative pancreatic resection due to portomesenteric hypertension and collateral venous drainage.

METHODS:

Patients with portomesenteric occlusion undergoing pancreatectomy were identified between 2007 and 2020 at Stanford University Hospital. Demographic and clinical data, technique and perioperative factors, and post-operative outcomes were analyzed.

RESULTS:

Of twenty-seven (27) patients undergoing venous revascularization during pancreatectomy, most (15) were for pancreatic neuroendocrine tumor. Occlusions occurred mostly at the portosplenic confluence (15). Median occlusion length was 4.0 cm [3.1-5.8]. Regarding revascularization strategy, mesocaval shunting was used in 11 patients, in-line venous revascularization with internal jugular conduit in three patients, traditional venous resection and reconstruction in 9 patients, and thrombectomy in two patients. Median cohort operative time and estimated blood loss were 522 min [433-638] and 1000 mL [700-2500], respectively. Median length of stay was 10 days [8-14.5] with overall readmission rate of 37%. Significant complications occurred in 44% of patients despite only one (4%) perioperative mortality.

DISCUSSION:

Despite the technical complexity for managing portomesenteric occlusions, early revascularization strategies including mesocaval shunting or in-line venous revascularization are feasible and facilitate a safe pancreatic resection for surgically fit patients.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article